Sunshine Biopharma (SBFM) Competitors $1.50 +0.02 (+1.35%) Closing price 09/12/2025 03:57 PM EasternExtended Trading$1.47 -0.03 (-2.00%) As of 09/12/2025 07:31 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock SBFM vs. MIRA, FBLG, CVKD, ENLV, ALLR, NAII, NEUP, PASG, SNYR, and NNVCShould you be buying Sunshine Biopharma stock or one of its competitors? The main competitors of Sunshine Biopharma include MIRA Pharmaceuticals (MIRA), FibroBiologics (FBLG), Cadrenal Therapeutics (CVKD), Enlivex Therapeutics (ENLV), Allarity Therapeutics (ALLR), Natural Alternatives International (NAII), Neuphoria Therapeutics (NEUP), Passage Bio (PASG), Synergy CHC (SNYR), and NanoViricides (NNVC). These companies are all part of the "pharmaceutical products" industry. Sunshine Biopharma vs. Its Competitors MIRA Pharmaceuticals FibroBiologics Cadrenal Therapeutics Enlivex Therapeutics Allarity Therapeutics Natural Alternatives International Neuphoria Therapeutics Passage Bio Synergy CHC NanoViricides MIRA Pharmaceuticals (NASDAQ:MIRA) and Sunshine Biopharma (NASDAQ:SBFM) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their analyst recommendations, risk, valuation, dividends, media sentiment, profitability, earnings and institutional ownership. Which has more risk & volatility, MIRA or SBFM? MIRA Pharmaceuticals has a beta of 1.75, indicating that its stock price is 75% more volatile than the S&P 500. Comparatively, Sunshine Biopharma has a beta of 1.46, indicating that its stock price is 46% more volatile than the S&P 500. Do analysts recommend MIRA or SBFM? MIRA Pharmaceuticals presently has a consensus price target of $17.00, indicating a potential upside of 1,072.41%. Sunshine Biopharma has a consensus price target of $15.00, indicating a potential upside of 900.00%. Given MIRA Pharmaceuticals' stronger consensus rating and higher possible upside, research analysts clearly believe MIRA Pharmaceuticals is more favorable than Sunshine Biopharma.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score MIRA Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 3.50Sunshine Biopharma 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Does the media prefer MIRA or SBFM? In the previous week, MIRA Pharmaceuticals had 4 more articles in the media than Sunshine Biopharma. MarketBeat recorded 5 mentions for MIRA Pharmaceuticals and 1 mentions for Sunshine Biopharma. Sunshine Biopharma's average media sentiment score of 1.92 beat MIRA Pharmaceuticals' score of 0.74 indicating that Sunshine Biopharma is being referred to more favorably in the news media. Company Overall Sentiment MIRA Pharmaceuticals Positive Sunshine Biopharma Very Positive Which has stronger earnings & valuation, MIRA or SBFM? Sunshine Biopharma has higher revenue and earnings than MIRA Pharmaceuticals. MIRA Pharmaceuticals is trading at a lower price-to-earnings ratio than Sunshine Biopharma, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMIRA PharmaceuticalsN/AN/A-$7.85M-$0.49-2.96Sunshine Biopharma$34.87M0.20-$5.13M-$150.88-0.01 Do institutionals & insiders have more ownership in MIRA or SBFM? 35.2% of MIRA Pharmaceuticals shares are held by institutional investors. Comparatively, 42.0% of Sunshine Biopharma shares are held by institutional investors. 6.7% of MIRA Pharmaceuticals shares are held by insiders. Comparatively, 0.1% of Sunshine Biopharma shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth. Is MIRA or SBFM more profitable? MIRA Pharmaceuticals has a net margin of 0.00% compared to Sunshine Biopharma's net margin of -17.35%. Sunshine Biopharma's return on equity of -26.04% beat MIRA Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets MIRA PharmaceuticalsN/A -406.70% -328.44% Sunshine Biopharma -17.35%-26.04%-20.72% SummaryMIRA Pharmaceuticals beats Sunshine Biopharma on 8 of the 15 factors compared between the two stocks. Get Sunshine Biopharma News Delivered to You Automatically Sign up to receive the latest news and ratings for SBFM and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding SBFM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SBFM vs. The Competition Export to ExcelMetricSunshine BiopharmaMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$6.74M$3.20B$5.87B$10.13BDividend YieldN/A2.30%5.68%4.60%P/E Ratio-0.0121.1774.5225.93Price / Sales0.20427.09516.21181.52Price / CashN/A46.6837.5660.44Price / Book0.169.6112.166.29Net Income-$5.13M-$53.29M$3.28B$270.77M7 Day Performance10.70%0.12%0.78%3.84%1 Month PerformanceN/A5.60%4.87%4.85%1 Year Performance-46.43%10.47%60.72%26.00% Sunshine Biopharma Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SBFMSunshine Biopharma2.914 of 5 stars$1.50+1.4%$15.00+900.0%-46.4%$6.74M$34.87M-0.013Positive NewsMIRAMIRA Pharmaceuticals3.1974 of 5 stars$1.37-0.4%$17.00+1,145.4%+8.2%$25.94MN/A-2.782News CoveragePositive NewsShort Interest ↓Gap UpFBLGFibroBiologics3.0977 of 5 stars$0.62+4.9%$13.00+2,000.2%-82.8%$25.93MN/A-1.7210News CoverageAnalyst ForecastCVKDCadrenal Therapeutics3.1957 of 5 stars$12.52-3.4%$32.00+155.6%+22.7%$25.67MN/A-1.414Short Interest ↓Gap DownENLVEnlivex Therapeutics2.5407 of 5 stars$1.04-1.0%$10.00+861.5%-32.7%$24.60MN/A-1.5870News CoverageAnalyst ForecastShort Interest ↑ALLRAllarity Therapeutics1.9322 of 5 stars$1.62+4.9%$9.00+457.3%-42.4%$23.70MN/A0.0010Short Interest ↑NAIINatural Alternatives International1.6423 of 5 stars$3.80+6.1%N/A-44.0%$23.48M$113.80M-2.73290Positive NewsShort Interest ↓Gap DownNEUPNeuphoria Therapeutics2.5845 of 5 stars$12.05+6.4%$21.00+74.3%N/A$22.65M$10K0.00N/ANews CoverageAnalyst ForecastPASGPassage Bio3.9345 of 5 stars$7.07-0.9%$91.75+1,198.7%-53.1%$22.47MN/A-0.39130SNYRSynergy CHC4.0739 of 5 stars$2.37-2.1%$10.00+321.9%+980.0%$22.37M$34.83M6.2440News CoverageNNVCNanoViricides0.1536 of 5 stars$1.39flatN/A-13.7%$22.34MN/A-1.9320Short Interest ↑ Related Companies and Tools Related Companies MIRA Competitors FBLG Competitors CVKD Competitors ENLV Competitors ALLR Competitors NAII Competitors NEUP Competitors PASG Competitors SNYR Competitors NNVC Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SBFM) was last updated on 9/13/2025 by MarketBeat.com Staff From Our PartnersWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredOctober 16 Changes the Microchip Game — and InvestingWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sunshine Biopharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sunshine Biopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
